CytoSorbents

CytoSorbents CytoSorbents Corporation is a critical care focused immunotherapy company using blood purification t

CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based company involved in the R&D and commercialization of medical devices using its proprietary polymer adsorption technology. CytoSorbents is a leader in the treatment of life-threatening conditions in the ICU and cardiac surgery using blood purification. Its flagship product, CytoSorb®, is distributed in more than 70 countries and has CE Mark approval in the EU for cytokine, bilirubin and myoglobin removal in numerous critical care applications and the removal of ticagrelor and rivaroxaban during cardiothoracic surgery. CytoSorbents has multiple active, clinical trials ongoing, including two pivotal randomized, controlled trials in the United States designed to support eventual FDA marketing approval for antithrombotic removal during cardiothoracic surgery using the DrugSorb™-ATR Antithrombotic Removal System.

🎆 Goodbye 2025 – Hello 2026! 🎆As the year draws to a close, we take a moment to pause, reflect, and look ahead. 2025 was...
12/31/2025

🎆 Goodbye 2025 – Hello 2026! 🎆
As the year draws to a close, we take a moment to pause, reflect, and look ahead. 2025 was filled with challenges, growth, and countless moments of collaboration and inspiration.

To everyone who walked this path with us — thank you.
Let’s welcome 2026 with curiosity, courage, and hope for all that lies ahead.

✨ Wishing you a joyful New Year’s Eve and a bright, healthy, and peaceful start to the new year! ✨

🎄✨ Day 24: Happy Holidays! ✨🎄As we open the last door of our Advent Calendar, we wish you and your loved ones a holiday ...
12/24/2025

🎄✨ Day 24: Happy Holidays! ✨🎄

As we open the last door of our Advent Calendar, we wish you and your loved ones a holiday season filled with warmth, joy, and togetherness. Thank you for being part of our community this year! Here’s to a wonderful holiday and a bright year ahead!
🎉🎁 https://cyto.news/adventcalendar

This is the season for excitement! 🌟 As we enter the busiest part of the year, our   Digital Advent Calendar offers a da...
12/22/2025

This is the season for excitement! 🌟
As we enter the busiest part of the year, our Digital Advent Calendar offers a daily mix of insights, seasonal inspiration, and small reflective pauses.
👉 Discover all daily entries here: https://cyto.news/adventcalendar

🎄✨

Rückblick auf unsere Webinarreihe „Medizincontrolling: Wissen kompakt“Unsere diesjährige Webinarreihe bot einen kompakte...
12/19/2025

Rückblick auf unsere Webinarreihe „Medizincontrolling: Wissen kompakt“

Unsere diesjährige Webinarreihe bot einen kompakten Überblick über zentrale Themen des Medizincontrollings – von den rechtlichen Rahmenbedingungen der ärztlichen Dokumentation bis hin zu praxisnahen Kriterien für die Indikationsstellung und Kodierung der Hämoadsorption.

Mit Expertinnen und Experten aus Recht, Medizin und Reimbursement haben wir aktuelle Herausforderungen beleuchtet, typische Fallstricke aufgezeigt und konkrete Handlungsempfehlungen für die tägliche Praxis vermittelt. Die hohe Teilnahme und die fachlich fundierten Diskussionen zeigen, wie groß der Bedarf an präzisem, interdisziplinärem Wissen im Klinikalltag ist.

Wir bedanken uns bei allen Teilnehmenden sowie den Referentinnen und Referenten für den wertvollen Austausch. Die Reihe wird auch künftig fortgesetzt – mit weiteren praxisorientierten Impulsen für eine sichere und effiziente Dokumentation.

  that Sir William Osler passed away on December 29, 1919, in Oxford, leaving a transformative legacy that shaped modern...
12/17/2025

that Sir William Osler passed away on December 29, 1919, in Oxford, leaving a transformative legacy that shaped modern medical education and clinical care worldwide? Recognized as the “Father of Modern Medicine,” Osler ushered in a new era of patient-centered learning, scientific rigor, and compassionate bedside practice.

Osler revolutionized medical training by pioneering bedside teaching — believing that physicians must learn directly from patients rather than solely from lectures or textbooks. As one of the founding professors at Johns Hopkins Hospital, he helped establish the residency system, which remains the global model for postgraduate medical education and clinical specialization today.

A meticulous clinician and sharp observer, Osler emphasized treating the patient as a whole, not just managing disease. Decades before critical-care medicine and immunopathology matured as fields, he recognized the central role of host response in illness, noting that patients often succumb not to infection alone, but to the body’s reaction to it — a concept that resonates profoundly with contemporary understanding of sepsis, inflammation, and multi-organ dysfunction.

Beyond his scientific contributions, Osler championed humility, lifelong learning, and professional ethics. His teachings continue to influence modern ICUs and academic centers, reminding clinicians that clinical excellence is built on knowledge, curiosity, and humanity at the bedside.

12/16/2025

📌 CytoSorb Case Report:
A 23-year-old kidney transplant recipient developed severe cytokine release syndrome (CRS) after receiving anti-thymocyte globulin (ATG) — a critical immunosuppressive drug used to prevent rejection.

Within hours, he went into multi-organ failure: respiratory distress, renal dysfunction, and circulatory collapse requiring multiple vasopressors.
The intensive care team at the University of Pisa integrated CytoSorb hemoadsorption into the continuous renal replacement therapy (CRRT) to help remove circulating cytokines and stabilize the patient.

After three consecutive 24-hour sessions, his blood pressure stabilized, kidney function returned, and he was extubated day nine. The SOFA score decreased from 17 to 4.
This case underscores the importance of early immune modulation in managing post-transplant inflammatory crises — and the potential of CytoSorb as an adjunct in cytokine-driven complications.
👉 CytoSorb — restoring balance when inflammation threatens recovery.
📑 Full case: https://cytosorbents.com/lit-db/infoitem/11656__2025-05-20__belfiore-j

Every December, professionals everywhere rediscover their curiosity through an unusual tradition: opening 24 doors one b...
12/16/2025

Every December, professionals everywhere rediscover their curiosity through an unusual tradition: opening 24 doors one by one. Our CytoSorbents Advent Calendar turns this habit into a daily journey through science, teamwork and unexpected insights.
Open today’s door and share which topics you would like to see featured next.
👉 https://cyto.news/adventcalendar

❤️ CytoSorbents auf dem DGTHG 2026 in KölnVorankündigungVom 21.–23. Februar 2026 trifft sich die Herz-, Thorax- und Gefä...
12/12/2025

❤️ CytoSorbents auf dem DGTHG 2026 in Köln

Vorankündigung
Vom 21.–23. Februar 2026 trifft sich die Herz-, Thorax- und Gefäßchirurgie-Community zur 55. Jahrestagung der Deutschen Gesellschaft für Thorax-, Herz- und Gefäßchirurgie (DGTHG) in Köln und bringt führende Expert:innen zusammen. Über drei Tage werden aktuelle wissenschaftliche Erkenntnisse, praxisnahe Einblicke sowie wegweisende Innovationen geboten. Ein unverzichtbares Forum für alle, die in der Thorax-, Herz- und Gefäßchirurgie tätig sind und sich vernetzen, weiterbilden und inspirieren lassen möchten.

Auch CytoSorbents ist wieder mit dabei und freut sich auf den fachlichen Austausch zu Themen wie inflammatorisches Management, Organprotektion und perioperative Hämoadsorption.

Merken Sie sich außerdem bereits heute unser Symposium am Samstag, 21. Februar 2026 zum Thema "Hemoadsorption in cardiac surgery – New insights" vor.
Das vollständige Programm und weitere Informationen finden Sie hier
👉 https://cytosorbents.com/event/dgthg-2026/
Wir freuen uns auf spannende Gespräche, neue Impulse und ein Wiedersehen in Köln!

Address

305 College Road East
Princeton, NJ
08540

Alerts

Be the first to know and let us send you an email when CytoSorbents posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to CytoSorbents:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram